{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:52:42Z","timestamp":1782906762921,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.canrad.2026.104830","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:02:53Z","timestamp":1780056173000},"page":"104830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary uveal diffuse large B-cell lymphoma: A population-based study"],"prefix":"10.1016","volume":"30","author":[{"given":"Pierre","family":"Loap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2026.104830_bib0070","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0277-5379(89)90416-1","article-title":"Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry","volume":"25","author":"Otter","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.canrad.2026.104830_bib0075","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00066-025-02404-0","article-title":"Radiotherapy of localized orbital mantle cell lymphoma: a\u00a0SEER database analysis of long-term outcomes","volume":"201","author":"Loap","year":"2025","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2026.104830_bib0080","doi-asserted-by":"crossref","first-page":"104629","DOI":"10.1016\/j.canrad.2025.104629","article-title":"Comprehensive analysis of uveal mucosa-associated lymphoid tissue lymphomas: epidemiological insights and radiotherapy utilization from the Surveillance, Epidemiology and End Results database","volume":"29","author":"Loap","year":"2025","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104830_bib0085","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ophtha.2013.09.004","article-title":"Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes","volume":"121","author":"Aronow","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.canrad.2026.104830_bib0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.survophthal.2019.10.008","article-title":"Large B-cell lymphoma of the uvea: histopathologic variants and clinicopathologic correlation","volume":"65","author":"Valenzuela","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.canrad.2026.104830_bib0095","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1634\/theoncologist.8-6-541","article-title":"Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program","volume":"8","author":"Gloeckler Ries","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.canrad.2026.104830_bib0100","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/bjh.13766","article-title":"Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era","volume":"171","author":"Kumar","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.canrad.2026.104830_bib0105","series-title":"Retina, fifth edition, volume 1, part 2. Basic science and translation to therapy","article-title":"Chapter 27\u00a0\u2013\u00a0blood\u2013retinal barrier, immune privilege, and autoimmunity","author":"Katamay","year":"2013"},{"key":"10.1016\/j.canrad.2026.104830_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104830_bib0115","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.annonc.2025.07.014","article-title":"Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Eyre","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2026.104830_bib0120","series-title":"Annual update in intensive care and emergency medicine 2018","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-73670-9_43","article-title":"Rituximab-related severe toxicity","author":"Ghrenassia","year":"2018"},{"key":"10.1016\/j.canrad.2026.104830_bib0125","first-page":"22","article-title":"A case of irreversible bradycardia after rituximab therapy for diffuse large B-cell lymphoma","volume":"6","author":"Ko Ko","year":"2020","journal-title":"Cardiooncology"},{"key":"10.1016\/j.canrad.2026.104830_bib0130","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood.2020008235","article-title":"Primary vitreoretinal lymphoma: a diagnostic and management challenge","volume":"138","author":"Soussain","year":"2021","journal-title":"Blood"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321826000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321826000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:37:52Z","timestamp":1782905872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321826000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1278321826000338"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104830","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary uveal diffuse large B-cell lymphoma: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}],"article-number":"104830"}}